Overview

TREAD-20 Extension - Treatment of Knee Pain Due to Osteoarthritis

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
This extended study will evaluate the efficacy and safety of intra-articular injections of 20mg/2ml dose HYALGAN in patients with pain due to osteoarthritis (OA) of the knee.
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Hyaluronic Acid